Copyright
©The Author(s) 2025.
World J Gastrointest Pharmacol Ther. Mar 5, 2025; 16(1): 97918
Published online Mar 5, 2025. doi: 10.4292/wjgpt.v16.i1.97918
Published online Mar 5, 2025. doi: 10.4292/wjgpt.v16.i1.97918
Table 5 Pooled prevalence of gastroesophageal reflux disease according to geographical location
Geographical location | Number of studies used for calculation by Nirwan et al[34], 2020 | Number of participants | GERD prevalence, % |
Global | |||
Overall | 102 | 469899 | 13.98 |
Male | 50 | 122849 | 15.69 |
Female | 50 | 138435 | 17.17 |
Hemisphere | |||
Western | 10-20[6,55] | ||
Eastern | 2-7[6,127] | ||
Continents | |||
Asia | 54 | 240451 | 12.92 |
Europe | 29 | 90057 | 14.12 |
North America | 9 | 20525 | 19.55 |
Latin America and the Caribbean | 4 | 12756 | 12.88 |
Oceania | 4 | 3760 | 13.78 |
Africa | 2 | 2350 | NA |
Countries | |||
China | 10 | 36887 | 4.16 |
Japan | 7 | 27912 | 13.81 |
South Korea | 7 | 43897 | 5.84 |
Taiwan | 1 | 1238 | NA |
Indonesia | 1 | 278 | NA |
Bangladesh | 1 | 2000 | 5.25[56] |
India | 3 | 6296 | NA |
Iran | 16 | 102295 | 18.43 |
Turkey | 4 | 13332 | 22.4 |
Israel | 2 | 3008 | NA |
Saudi Arabia | 2 | 3308 | NA |
Poland | 1 | 850 | NA |
Romania | 1 | 184 | NA |
Russia | 2 | 8877 | NA |
Albania | 1 | 845 | NA |
Italy | 2 | 2032 | NA |
Greece | 1 | 700 | NA |
Spain | 3 | 5365 | NA |
Switzerland | 2 | 7736 | NA |
Netherlands | 1 | 502 | NA |
France | 2 | 46377 | NA |
Germany | 1 | 268 | NA |
Sweden | 4 | 8120 | 16.15 |
Finland | 1 | 1700 | NA |
Norway | 1 | 44997 | NA |
United Kingdom | 4 | 12467 | 14.53 |
Denmark | 1 | 48027 | NA |
United States | 8 | 19489 | 21.04 |
Canada | 1 | 1036 | NA |
Argentina | 1 | 839 | NA |
Brazil | 1 | 3934 | NA |
Uruguay | 1 | 1141 | NA |
Colombia | 1 | 6842 | NA |
Australia | 3 | 2982 | 12[62], 9.2[63] |
New Zealand | 1 | 778 | NA |
Nigeria | 1 | 410 | NA |
Côte d’Ivoire | 1 | 1940 | NA |
Sri Lanka | 1 | 1200 | 23.5[59] |
- Citation: Wickramasinghe N, Devanarayana NM. Insight into global burden of gastroesophageal reflux disease: Understanding its reach and impact. World J Gastrointest Pharmacol Ther 2025; 16(1): 97918
- URL: https://www.wjgnet.com/2150-5349/full/v16/i1/97918.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v16.i1.97918